← All trials
NCT05676684
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 15, 2022
- Primary completion
- Sep 15, 2024
- Completion date
- Dec 15, 2024
- First posted
- Jan 9, 2023
- Last posted
- Oct 19, 2023
- Enrollment
- 108
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PortoLead sponsor
- Centro Hospitalar de Vila Nova de Gaia/EspinhoCollaborator
- University Hospital Center of Sao Joao (UHCSJ)Collaborator
- University of PortoOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.